The most common complaints include mild injection site irritation, temporary fatigue, or slight changes in appetite
[...] Rated 4 out of 5 Vera My endurance improved while losing weight
Many patients use semaglutide 0.251mg weekly injections for several months to a year to achieve meaningful weight reduction
In contrast, short-acting formulations such as exenatide and the older-generation agent lixisenatide are now prescribed far less frequently, and several formulations have been withdrawn from the market in certain countries, largely due to limited clinical uptake, the availability of more effective long-acting alternatives, and commercial considerations rather than confirmed safety concerns
A clinical trial in Parkinsons disease patients using systemic administrations of the GLP1-R agonist exendin-4 in an extended release formulation has demonstrated clinical efficacy (Athauda et al, 2017)
Peak appetite reduction occurs around week 12 when reaching maintenance dose